Combined modality treatment of glioblastoma multiforme: the role of temozolomide.

Reviews on recent clinical trials

Volumn 1, Issue 1, 2006, Pages 43-51

  Nieder, Carsten ^a   Adam, Markus ^a   Grosu, Anca L ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE;

BRAIN TUMOR; GLIOBLASTOMA; HUMAN; MULTIMODALITY CANCER THERAPY; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; GLIOBLASTOMA; HUMANS; PROGNOSIS; TREATMENT OUTCOME;

EID: 33947526072     PISSN: 15748871     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488706775246148     Document Type: Review

References (71)